Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, INTEGRA LIFESCIENCES HOLDINGS CORP reported revenue of $1.64B, up 1.5% year over year. Operating margin was -30.2% and net margin -31.6%, on a free-cash-flow margin of -1.9% with capital expenditure at 5.0% of revenue. Every figure is computed directly from IART's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $1.64B | -30.2% | -31.6% |
| FY2024 | $1.61B | 1.8% | -0.4% |
| FY2023 | $1.54B | 7.2% | 4.4% |
| FY2022 | $1.56B | 15.3% | 11.6% |
| FY2021 | $1.54B | 12.8% | 11.0% |
How does IART compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.